I

107TH CONGRESS

1ST SESSION S. 1094

IN THE HOUSE OF REPRESENTATIVES

NOVEMBER 19, 2001

Referred to the Committee on Energy and Commerce

AN ACT

To amend the Public Health Service Act to provide for

research, information, and education with respect to

blood cancer.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Hematological Cancer

5 Research Investment and Education Act of 2001’’.
2

S 1094 RFH

1 SEC. 2. FINDINGS.

2 Congress finds that:

3 (1) An estimated 109,500 people in the United

4 States will be diagnosed with leukemia, lymphoma,

5 and multiple myeloma in 2001.

6 (2) New cases of the blood cancers described in

7 paragraph (1) account for 8.6 percent of new cancer

8 cases.

9 (3) Those devastating blood cancers will cause

10 the deaths of an estimated 60,300 persons in the

11 United States in 2001. Every 9 minutes, a person

12 in the United States dies from leukemia, lymphoma,

13 or multiple myeloma.

14 (4) While less than 5 percent of Federal funds

15 for cancer research are spent on those blood cancers,

16 those blood cancers cause 11 percent of all cancer

17 deaths in the United States.

18 (5) Increased Federal support of research into

19 leukemia, lymphoma, and multiple myeloma has re20 sulted and will continue to result in significant ad21 vances in the treatment, and ultimately the cure, of

22 those blood cancers as well as other cancers.
3

S 1094 RFH

1 SEC. 3. RESEARCH, INFORMATION, AND EDUCATION WITH

2 RESPECT TO BLOOD CANCER.

3 Part C of title IV of the Public Health Service Act

4 (42 U.S.C. 285 et seq.) is amended by inserting after sec5 tion 419C the following:

6 ‘‘SEC. 417D. RESEARCH, INFORMATION, AND EDUCATION

7 WITH RESPECT TO BLOOD CANCER.

8 ‘‘(a) JOE MOAKLEY RESEARCH EXCELLENCE PRO9 GRAM.—

10 ‘‘(1) IN GENERAL.—The Director of NIH shall

11 expand, intensify, and coordinate programs for the

12 conduct and support of research with respect to

13 blood cancer, and particularly with respect to leu14 kemia, lymphoma, and multiple myeloma.

15 ‘‘(2) ADMINISTRATION.—The Director of NIH

16 shall carry out this subsection through the Director

17 of the National Cancer Institute and in collaboration

18 with any other agencies that the Director determines

19 to be appropriate.

20 ‘‘(3) AUTHORIZATION OF APPROPRIATIONS.—

21 For the purpose of carrying out this subsection,

22 there is authorized to be appropriated such sums as

23 may be necessary for fiscal year 2002 and each sub24 sequent fiscal year. Such authorizations of appro25 priations are in addition to other authorizations of

26 appropriations that are available for such purpose.
4

S 1094 RFH

1 ‘‘(b) GERALDINE FERRARO CANCER EDUCATION

2 PROGRAM.—

3 ‘‘(1) IN GENERAL.—The Secretary shall direct

4 the appropriate agency within the Department of

5 Health and Human Services, in collaboration with

6 the Director of NIH, to establish and carry out a

7 program to provide information and education for

8 patients and the general public with respect to blood

9 cancer, and particularly with respect to the treat10 ment of leukemia, lymphoma, and multiple myeloma.

11 ‘‘(2) ADMINISTRATION.—The Agency deter12 mined by the Secretary under paragraph (1) shall

13 carry out this subsection in collaboration with pri14 vate health organizations that have national edu15 cation and patient assistance programs on blood-re16 lated cancers.

17 ‘‘(3) AUTHORIZATION OF APPROPRIATIONS.—

18 For the purpose of carrying out this subsection,

19 there is authorized to be appropriated such sums as

20 may be necessary for fiscal year 2002 and each sub21 sequent fiscal year. Such authorizations of appro22 priations are in addition to other authorizations of

23 appropriations that are available for such purpose.’’.

Passed the Senate November 16, 2001.

Attest: JERI THOMSON,

Secretary.